-

KARL STORZ Imaging Celebrates 30th Anniversary

GOLETA, Calif.--(BUSINESS WIRE)--KARL STORZ Imaging (KSI) of Goleta, California, celebrates its 30th anniversary on November 12, 2020. Since 1990, KSI has been a pillar of California’s Central Coast technology industry and is one of the area’s largest employers, with almost 400 team members.

KSI is a subsidiary of KARL STORZ SE & Co. KG, a family-owned company based in Germany that employs more than 8000 people in 44 countries. KARL STORZ is a world leader in endoscopes used for medical diagnostics and minimally invasive surgery, which can achieve shorter hospital stays and recovery times, with reduced pain and improved outcomes. As one of the largest privately held medical device companies in the world, KARL STORZ has achieved global preeminence in production and sales of endoscopes and medical imaging devices.

In 1990, KARL STORZ purchased the Goleta startup, Medical Concepts, Inc., creating KARL STORZ Imaging. For 30 years, this local high-tech company has thrived. KSI put down more permanent roots in 2014 by purchasing its current building at 1 South Los Carneros Rd. with an eye on expansion. This 100,000-plus square foot facility houses the internationally renowned product development group, integrated with high-tech manufacturing and service.

KSI has made significant advances in medicine while contributing to the economic growth of the Central Coast of California. This success was recognized in 2015 with the dedication of its street as Karl Storz Drive.

The KARL STORZ Imaging 30th anniversary celebration will be held virtually with global participants. They look forward to recognizing this historic company milestone with employees, the community, and special guests.

Contacts

KARL STORZ Endoscopy-America, Inc.


Release Versions

Contacts

More News From KARL STORZ Endoscopy-America, Inc.

ADDING MULTIMEDIA KARL STORZ Announces FDA Clearance for ENDOFLATOR + Insufflator and Smoke Evacuation System

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in minimally invasive surgical technology, is proud to announce it has received U.S. Food and Drug Administration (FDA) clearance for the ENDOFLATOR™ +. ENDOFLATOR + is the next-generation insufflator with integrated surgical smoke evacuation system designed to meet the evolving needs of modern operating rooms. Using carbon dioxide gas, an insufflator establishes and maintains a stable working cavity within the body during laparos...

KARL STORZ Unifies Canada, US, and Veterinary Organizations to Form North America Region Led by Sonal Matai

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a family-owned medical technology company headquartered in Tuttlingen, Germany, today announced the creation of a North America region that unifies its US, Canada, and Veterinary businesses under the leadership of Sonal Matai. Matai joined KARL STORZ in 2022 and was appointed to lead KARL STORZ United States in early 2024. As President of North America, Matai will now oversee key functions such as commercial operations, research and development,...

AventaMed, a KARL STORZ Company, Receives Expanded Indication for Solo+ Tympanostomy Tube Device (TTD)

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ United States is proud to announce that the US Food and Drug Administration (FDA) has cleared an expanded indication for the AventaMed Solo+™ Tympanostomy Tube Device (TTD), allowing its use in pediatric patients aged 6 months and older. This expanded clearance builds on the previous 510(k) clearance, which was indicated for patients 6 to 24 months old. The Solo+ device represents a significant advancement in pediatric ENT care. It is intended to...
Back to Newsroom